Oncoloxía
Institut d'Investigació Biomèdica Girona
Girona, EspañaPublicacións en colaboración con investigadores/as de Institut d'Investigació Biomèdica Girona (13)
2024
-
Atezolizumab Combined with Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer with a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial
Journal of Clinical Oncology
-
Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian Cancer
JAMA network open, Vol. 7, Núm. 4, pp. e247811
2023
-
SEOM clinical guideline on heritable TP53-related cancer syndrome (2022)
Clinical and Translational Oncology, Vol. 25, Núm. 9, pp. 2627-2633
2021
-
Are there differences by sex in lung cancer characteristics at diagnosis? -a nationwide study
Translational Lung Cancer Research, Vol. 10, Núm. 10, pp. 3902-3911
-
Trajectories of alcohol consumption during life and the risk of developing breast cancer
British Journal of Cancer, Vol. 125, Núm. 8, pp. 1168-1176
2020
2018
-
Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain
Psycho-Oncology, Vol. 27, Núm. 6, pp. 1530-1537
2013
2012
-
Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer
Breast Cancer Research and Treatment, Vol. 132, Núm. 1, pp. 307-315
-
What factors may influence psychological well being at three months and one year post BRCA genetic result disclosure?
Breast, Vol. 21, Núm. 6, pp. 755-760
2009
-
Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort
Human Reproduction, Vol. 24, Núm. 4, pp. 1000-1006
-
Xeroderma pigmentosum: Neck lymph node metastasis of a squamous cell carcinoma of the skin treated with cetuximab
European Journal of Dermatology, Vol. 19, Núm. 2, pp. 163-165
2008
-
BRCA1 and acetyl-CoA carboxylase: The metabolic syndrome of breast cancer
Molecular Carcinogenesis, Vol. 47, Núm. 2, pp. 157-163